On March 30, the PMDA held the “PMDA-ATC COVID-19 related Medical Products Webinar for the Drug Administration of Vietnam (DAV), Vietnam.”
The theme of the webinar was COVID-19 related Medical Products. The PMDA shared information on the Japanese review and pharmacovigilance system and PMDA’s experiences with 11 DAV regulators.
The PMDA continuously contributes to sharing information by seminars and strengthen collaboration with DAV.
See attached program.
Back
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
International Activities
Safety Information
Advanced Efforts
-
Information for approved products in Japan
Safety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulatory science
-
Regulations and services of PMDA
Information for approved products in Japan
Procedures in Japan
Advanced efforts
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
Safety information
Procedures in Japan
-
Reviews and Related Services
Regulatory Procedures
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety
Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC COVID-19 related Medical Products Webinar 2022 for DAV, Vietnam
Events and Symposia